Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
43.35
-0.01 (-0.02%)
At close: Jul 24, 2026, 4:00 PM EDT
43.46
+0.11 (0.26%)
After-hours: Jul 24, 2026, 7:53 PM EDT
Sanofi Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | - | 4,977 | 5,554 | 5,098 | 8,083 | 6,279 |
Depreciation & Amortization | - | 5,678 | 3,586 | 4,429 | 3,108 | 3,351 |
Stock-Based Compensation | - | 313 | 278 | 260 | 234 | 244 |
Other Adjustments | - | -5,224 | -3,570 | -3,547 | -3,651 | -2,370 |
Change in Receivables | - | -1,202 | -28 | -472 | -500 | 185 |
Changes in Inventories | - | -39 | -477 | -866 | -918 | -357 |
Changes in Accounts Payable | - | 398 | 789 | 258 | 340 | 451 |
Changes in Other Operating Activities | 4 | 2,827 | -425 | 2,480 | 1,172 | 1,130 |
Operating Cash Flow | 10,340 | 10,750 | 9,081 | 10,258 | 10,526 | 10,522 |
Operating Cash Flow Growth | -6.73% | 18.38% | -11.47% | -2.55% | 0.04% | 106.76% |
Capital Expenditures | - | -3,538 | -3,195 | -2,906 | -2,103 | -2,043 |
Sale of Property, Plant & Equipment | - | 847 | 1,461 | 807 | 1,340 | 676 |
Purchases of Investments | - | -684 | -623 | -134 | -487 | -311 |
Cash Acquisitions | - | -9,394 | -1,901 | -2,535 | -987 | -5,594 |
Proceeds from Business Divestments | - | - | - | 42 | 134 | 42 |
Other Investing Activities | -27 | 10,322 | -149 | -1,474 | 28 | -68 |
Investing Cash Flow | -3,949 | -2,447 | -4,407 | -6,200 | -2,075 | -7,298 |
Short-Term Debt Issued | - | -1,100 | 59 | 751 | 216 | -414 |
Net Short-Term Debt Issued (Repaid) | - | -1,100 | 59 | 751 | 216 | -414 |
Long-Term Debt Issued | - | 5,559 | - | 48 | 1,549 | - |
Long-Term Debt Repaid | - | -2,955 | -953 | -3,936 | -2,998 | -2,390 |
Net Long-Term Debt Issued (Repaid) | - | 2,604 | -953 | -3,888 | -1,449 | -2,390 |
Issuance of Common Stock | - | 177 | 187 | 195 | 188 | 186 |
Repurchase of Common Stock | - | -5,030 | -302 | -593 | -497 | -382 |
Net Common Stock Issued (Repurchased) | - | -4,853 | -115 | -398 | -309 | -196 |
Other Financing Activities | -40 | -48 | -12 | -7 | -14 | - |
Financing Cash Flow | -9,142 | -8,207 | -5,763 | -8,052 | -5,821 | -7,056 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -18 | -47 | -13 | -32 | 8 | 15 |
Net Cash Flow | -2,447 | 216 | -1,269 | -4,026 | 2,638 | -3,817 |
Free Cash Flow | 10,340 | 7,212 | 5,886 | 7,352 | 8,423 | 8,479 |
Free Cash Flow Growth | -6.73% | 22.53% | -19.94% | -12.72% | -0.66% | 182.07% |
FCF Margin | 21.84% | 15.44% | 13.29% | 17.67% | 20.77% | 21.64% |
Free Cash Flow Per Share | 4.26 | 2.94 | 2.34 | 2.93 | 3.35 | 3.37 |
Levered Free Cash Flow | 7,558 | 14,643 | 4,944 | 5,658 | 8,737 | 5,951 |
Unlevered Free Cash Flow | 5,175 | 10,598 | 6,226 | 9,223 | 9,809 | 9,034 |